Company Growth (employees)
GlaxoSmithKline was founded in 2001 and is headquartered in Brentford, GB
Key People at GlaxoSmithKline
Andrew Philip Witty
CEO
Emma Walmsley
CEO of GSK Consumer Healthcare
Simon Dingemans
CFO
David Redfern
CSO
Dan Troy
General Counsel
Philip Thomson
SVP Global Communications & Government Affairs
GlaxoSmithKline Office Locations
GlaxoSmithKline has offices in Brentford, Tirana, Boudouaou Est, Buenos Aires and in 145 other locations
Brentford, GB (HQ)
980 Great West Road
Wavre, BE
Site Apollo, Pascal Avenue, 2-4-6
Minsk, BY
Office 905, 7a Voronianskogo Street
Bangladesh, IN
Road # 138, Gulshan # 1, Dhaka - 1212
Baku, AZ
96 Nizami Street
Wien, AT
Euro Plaza, Gebäude I, 4. Stock, Wagenseilgasse 3
GlaxoSmithKline Data and Metrics
GlaxoSmithKline Financial Metrics
GlaxoSmithKline's revenue was reported to be £27.9 b in FY, 2016 which is a 17% increase from the previous period.
GBP
Revenue (FY, 2016) | 27.9 b |
Revenue growth (FY, 2015 - FY, 2016), % | 17% |
Gross profit (FY, 2016) | 18.6 b |
Gross profit margin (FY, 2016), % | 67% |
Net income (FY, 2016) | 1.1 b |
Market capitalization (25-Jul-2017) | 102.5 b |
Closing share price (25-Jul-2017) | 42.2 |
Cash (31-Dec-2016) | 4.9 b |
GlaxoSmithKline's current market capitalization is $102.5 b.
- Source: Company Filings, Company Filings
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 26.5 b | 23 b | 23.9 b | 27.9 b |
Revenue growth, % | (13%) | 4% | 17% | |
Cost of goods sold | 8.6 b | 7.3 b | 8.9 b | 9.3 b |
Gross profit | 17.9 b | 15.7 b | 15.1 b | 18.6 b |
Gross profit Margin, % | 68% | 68% | 63% | 67% |
Sales and marketing expense | 8.5 b | 8.2 b | 9.2 b | 9.4 b |
R&D expense | 3.9 b | 3.5 b | 3.6 b | 3.6 b |
Operating expense total | 10.9 b | 12.1 b | 12.8 b | 13 b |
Interest expense | 767 m | 727 m | 757 m | 736 m |
Interest income | 104 m | 68 m | 104 m | 72 m |
Pre tax profit | 6.6 b | 3 b | 10.5 b | 1.9 b |
Income tax expense | 1 b | 137 m | 2.2 b | 877 m |
Net Income | 5.6 b | 2.8 b | 8.4 b | 1.1 b |
- Source: Company Filings, Company Filings
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 5.5 b | 4.3 b | 5.8 b | 4.9 b |
Accounts Receivable | 4 b | 3.6 b | 3.9 b | 4.7 b |
Current Assets | 15.2 b | 14.7 b | 16.6 b | 16.7 b |
PP&E | 13.4 b | 13.9 b | 15 b | 17.6 b |
Goodwill | 13.5 b | 12 b | 21.8 b | 24.7 b |
Total Assets | 42.1 b | 40.7 b | 53.4 b | 59.1 b |
Accounts Payable | 2.7 b | 2.8 b | 3.1 b | 3.6 b |
Current Liabilities | 13.7 b | 13.3 b | 13.4 b | 19 b |
Total Liabilities | 35.1 b | 36.4 b | 48.3 b | 58 b |
Retained Earnings | 1.9 b | (1.1 b) | 4.6 b | (3.9 b) |
Total Equity | 7 b | 4.3 b | 5.1 b | 1.1 b |
Financial Leverage | 6 x | 9.5 x | 10.5 x | 52.6 x |
| GBP | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash From Operating Activities | 2.6 b | 5.2 b | 7.2 b | 6.5 b |
Cash From Financing Activities | (6.3 b) | (5.4 b) | (7.1 b) | (6.4 b) |
Income Taxes Paid | (1 b) | (137 m) | (2.2 b) | (877 m) |
| Y, 2016 | |
|---|---|
Financial Leverage | 52.6 x |
GlaxoSmithKline Operating Metrics
GlaxoSmithKline's Unique Visitors was reported to be 1.8 m in FY, 2016
GlaxoSmithKline Market Value History
GlaxoSmithKline Revenue Breakdown
GlaxoSmithKline Median Salaries
Source: 173 public H-1B filings from GlaxoSmithKline
